Compare Abeona Therapeutics Inc (ABEO) vs ARK Autonomous Technology & Robotics ETF (ARKQ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs ARK Autonomous Technology & Robotics ETF — how do they compare? Abeona Therapeutics Inc trades at $6.73 (market cap $373.32M), while ARK Autonomous Technology & Robotics ETF trades at $123.81. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, ARK Autonomous Technology & Robotics ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | ARKQ | |
|---|---|---|
Market Cap | $373.32M | — |
Sector | Health | Sector/Thematic |
52-Week High | $7.23 | $143.82 |
52-Week Low | $4.17 | $88.47 |
Enterprise Value | $228.22M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
ARKQ trades at $130.11, up 1.7% on the day, with a bearish technical signal from moving averages and neutral oscillators. The ETF focuses on autonomous technology and robotics, benefiting from AI momentum, with assets under management reaching $2.7 billion as of April 2026 (Seeking Alpha, 2026-04-26). Recent news highlights sector growth in AI, robotics, and autonomous vehicles, though valuation metrics like P/E are not provided in the current data.
Outlook remains tied to AI and robotics adoption, with potential from themes like humanoid robots and autonomous driving. Risks include high valuations, sector volatility, and reliance on tech spending. Analyst sentiment is mixed, with some upgrades citing growth potential but technical indicators suggesting near-term caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About ARK Autonomous Technology & Robotics ETF
ARKQ is an actively managed ETF that invests in autonomous technology and robotics. It focuses on disruptive innovations like autonomous mobility, electric vehicles, 3D printing, and energy storage, with holdings such as Tesla and Teradyne.
Read more on ARKQ →
